Pisanti S - Search Results

1

Tumor-Associated Macrophage Status in Cancer Treatment.

Malfitano AM, Pisanti S, Napolitano F, Di Somma S, Martinelli R, Portella G. Malfitano AM, et al. Among authors: pisanti s. Cancers (Basel). 2020 Jul 21;12(7):1987. doi: 10.3390/cancers12071987. Cancers (Basel). 2020. PMID: 32708142 Free PMC article. Review.

2

Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis.

Malfitano AM, Matarese G, Pisanti S, Grimaldi C, Laezza C, Bisogno T, Di Marzo V, Lechler RI, Bifulco M. Malfitano AM, et al. Among authors: pisanti s. J Neuroimmunol. 2006 Feb;171(1-2):110-9. doi: 10.1016/j.jneuroim.2005.09.005. Epub 2005 Oct 18. J Neuroimmunol. 2006. PMID: 16239036

3

Anandamide inhibits adhesion and migration of breast cancer cells.

Grimaldi C, Pisanti S, Laezza C, Malfitano AM, Santoro A, Vitale M, Caruso MG, Notarnicola M, Iacuzzo I, Portella G, Di Marzo V, Bifulco M. Grimaldi C, et al. Among authors: pisanti s. Exp Cell Res. 2006 Feb 15;312(4):363-73. doi: 10.1016/j.yexcr.2005.10.024. Epub 2005 Dec 15. Exp Cell Res. 2006. PMID: 16343481

4

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.

Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V. Ligresti A, et al. Among authors: pisanti s. J Pharmacol Exp Ther. 2006 Sep;318(3):1375-87. doi: 10.1124/jpet.106.105247. Epub 2006 May 25. J Pharmacol Exp Ther. 2006. PMID: 16728591

5

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.

Sarnataro D, Pisanti S, Santoro A, Gazzerro P, Malfitano AM, Laezza C, Bifulco M. Sarnataro D, et al. Among authors: pisanti s. Mol Pharmacol. 2006 Oct;70(4):1298-306. doi: 10.1124/mol.106.025601. Epub 2006 Jul 5. Mol Pharmacol. 2006. PMID: 16822929

6

Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells.

Malfitano AM, Laezza C, Pisanti S, Gazzerro P, Bifulco M. Malfitano AM, et al. Among authors: pisanti s. Br J Pharmacol. 2008 Mar;153(5):1003-10. doi: 10.1038/sj.bjp.0707651. Epub 2007 Dec 24. Br J Pharmacol. 2008. PMID: 18157162 Free PMC article.

7

Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer".

Santoro A, Gazzerro P, Malfitano AM, Pisanti S, Laezza C, Bifulco M. Santoro A, et al. Among authors: pisanti s. Int J Cancer. 2008 Jul 1;123(1):243-4. doi: 10.1002/ijc.23507. Int J Cancer. 2008. PMID: 18395892 No abstract available.

8

Endocannabinoids in endocrine and related tumours.

Bifulco M, Malfitano AM, Pisanti S, Laezza C. Bifulco M, et al. Among authors: pisanti s. Endocr Relat Cancer. 2008 Jun;15(2):391-408. doi: 10.1677/ERC-07-0258. Endocr Relat Cancer. 2008. PMID: 18508995 Review.

9

The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.

Laezza C, Pisanti S, Malfitano AM, Bifulco M. Laezza C, et al. Among authors: pisanti s. Endocr Relat Cancer. 2008 Dec;15(4):965-74. doi: 10.1677/ERC-08-0030. Epub 2008 Aug 1. Endocr Relat Cancer. 2008. PMID: 18676619

10

Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state.

Laezza C, Fiorentino L, Pisanti S, Gazzerro P, Caraglia M, Portella G, Vitale M, Bifulco M. Laezza C, et al. Among authors: pisanti s. J Mol Med (Berl). 2008 Dec;86(12):1341-51. doi: 10.1007/s00109-008-0396-1. Epub 2008 Sep 9. J Mol Med (Berl). 2008. PMID: 18779944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters